Sector Update: Healthcare Shares Higher Pre-Market; Pluristem up 3.5% on Study Results

By Staff,

Shutterstock photo

Healthcare stocks:

JNJ: +0.35%

PFE: -0.1%

ABT: flat

MRK: +1.6%

AMGN: flat

Healthcare stocks are generally higher this morning, including bio-therapeutics company Pluristem Therapeutics Inc. ( PSTI ), which is up 3.5% in the pre-market session after reporting results from the study of its Placental expanded cells.

The developer of placenta-based cell therapies said PLX cells proved to be "safe" in an animal study assessing maternal and fetal toxicity. It will pursue the clinical development of PLX-PAD cells for the indication of pre-eclampsia based on these results, it also said.

And, Zalicus ( ZLCS ) shares are up 1.5% in pre-market trade as it reports quarterly loss of $0.46 per share, which is on par with what analysts expected. But it's revenue of $3.4 million missed the analysts' mark of $3.8 million, according to Capital IQ estimates.

Finally, shares of Achillion Pharmaceuticals Inc. ( ACHN ) has jumped near 3% in Monday's premarket session, after the biopharmaceutical company over the weekend released an encouraging preclinical profile of ACH-3422, a potential treatment of chronic hepatitis C viral infection or HCV, with its first-in-human and proof-of-concept trials expected in the first half of 2014.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2014 All rights reserved. Unauthorized reproduction is strictly prohibited.

This article appears in: Investing Commodities
Referenced Stocks: ACHN , PSTI , ZLCS

More from MT Newswires


MT Newswires

MT Newswires

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by